Atlas Trials

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Clinical trial NCT00396214 · TERMINATED

Trial details

NCT number
NCT00396214
Sponsor
Solvay Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2007-04-01
Primary completion
2008-01-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.